The National Cancer Institute is showcasing nanotechnology particles designed and produced by the lab of leading UNC Charlotte researcher Kirill Afonin on the cover of a document presented to the U.S. House and Senate appropriations committees. NCI is the principal federal agency for cancer research and training.
The image of nanotechnology particles in a culture of blood cells was developed by a team led by Afonin, a professor in the Department of Chemistry. The team developed the nano particles as part of its research on vaccine adjuvants, substances that enhance the body’s ability to produce an immune response.
Afonin and his team have collaborated closely with the NCI Nanotechnology Characterization Laboratory at the Frederick National Laboratory for Cancer Research. The lab helps cancer researchers study nanotechnology particles and characterize them by measuring their physical and chemical properties. The research seeks applications including cancer vaccines, other cancer therapeutics, and diagnostics.
Read more on the College of Liberal Arts & Sciences website.